
Android Bioscience Private Limited
This company manufactures a variety of pharmaceutical products, including syrups, drops, and suspensions.
This company manufactures a variety of pharmaceutical products, including syrups, drops, and suspensions.
Android Bioscience Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2012 and has a history of 12 years and nine months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹6.81 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gopal Vaghasia and Divyesh Sakariya serve as directors at the Company.
Vadodara, Gujarat, India
+91-XXXXXXXXXX
U24230GJ2012PTC070654
070654
Private Limited Indian Non-Government Company
08 Jun 2012
10 Sep 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Android Bioscience Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Ayurvedic Digestive Medicine, Digestive Enzyme Syrup, Anti Infective Agent, Ofloxacin Oral Suspension, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Allopathic Cough Syrup, Ambroxol Hydrochloride Syrup.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Divyesh Sakariya ![]() | Director | 21-Nov-2016 | Current |
Gopal Vaghasia ![]() | Director | 21-Nov-2016 | Current |
Android Bioscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.77% increase. The company also saw a substantial fall in profitability, with a 195.74% decrease in profit. The company's net worth dipped by a decrease of 3.76%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Android Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gopal Vaghasia and Divyesh Sakariya are mutual person
Gopal Vaghasia and Divyesh Sakariya are mutual person
₹0
₹68.10 M
Date | Lender | Amount | Status |
---|---|---|---|
07 Jun 2021 | Sidbi | ₹1.61 Cr | Satisfied |
06 Jul 2020 | Sidbi | ₹5.00 M | Satisfied |
27 Dec 2016 | Sidbi | ₹4.45 Cr | Satisfied |
08 Nov 2012 | Punjab National Bank | ₹2.50 M | Satisfied |
Unlock and access historical data on people associated with Android Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Android Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Android Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Android Bioscience Private Limited last Annual general meeting of members was held on 10 Sep 2024 as per latest MCA records.
A charge registered on 07 Jun 2021 via Charge ID 100451259 with Sidbi was fully satisfied on 09 Jul 2024.
A charge registered on 06 Jul 2020 via Charge ID 100359292 with Sidbi was fully satisfied on 09 Jul 2024.
A charge registered on 27 Dec 2016 via Charge ID 100070676 with Sidbi was fully satisfied on 09 Jul 2024.
Android Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
A charge with Sidbi amounted to Rs. 16.10 M with Charge ID 100451259 was registered on 07 Jun 2021.
Android Bioscience Private Limited was incorporated on 08 Jun 2012.
The authorized share capital of Android Bioscience Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Android Bioscience Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Android Bioscience Private Limited is C-21/A Sardar Estate, Ajwa Road India, Vadodara, Gujarat, 390019.
The corporate identification number (CIN) of Android Bioscience Private Limited is U24230GJ2012PTC070654 and the company number is 070654 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Android Bioscience Private Limited has risen by 23.77%.
The financial reports for the fiscal year 2022 indicates that The net worth of Android Bioscience Private Limited has experienced an downturn of -3.76%.
The most recent Balance Sheet for Android Bioscience Private Limited was filed with the ROC on 31 Mar 2024.
CV
KV
AP